SCHEMBL21135708

SCHEMBL21135708

NC(=O)C(N)Cc1cc#ccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC7A5 Q01650 3/20 0.39
▸ PTGS1 P23219 2/20 0.39
▸ ALPI P09923 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ XIAP P98170 1/20 0.39
▸ TPH1 P17752 1/20 0.38
▸ HSD17B10 Q99714 2/20 0.34
▸ SLC15A1 P46059 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ USP2 O75604 1/20 0.34
▸ EGFR P00533 1/20 0.34
▸ LCK P06239 1/20 0.34
▸ FYN P06241 1/20 0.34
▸ ADORA3 P0DMS8 1/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ HTR2A P28223 1/20 0.34
▸ PTGS2 P35354 1/20 0.34
▸ RECQL P46063 1/20 0.34
▸ HIF1A Q16665 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22060236 0.79 SLC15A1 (0.62) SLC7A5PTGS1ALPIPKMXIAP
SCHEMBL18822922 0.73 CA2 (0.47) KDM4E
Phenylalanine Amide SCHEMBL353251 0.71 SLC7A5 (0.73) SLC7A5PTGS1ALPIPKMXIAP
Phenylalanine Amide SCHEMBL244303 0.71 SLC7A5 (0.73) SLC7A5PTGS1ALPIPKMXIAP
Phenylalanine Amide SCHEMBL11349868 0.71 SLC7A5 (0.73) SLC7A5PTGS1ALPIPKMXIAP
Phenylalanine Amide SCHEMBL244302 0.71 SLC7A5 (0.73) SLC7A5PTGS1ALPIPKMXIAP
Phenylalanine Amide SCHEMBL23002157 0.69 SLC7A5 (0.70) SLC7A5PTGS1ALPIPKMXIAP
SCHEMBL918401 0.69 SLC7A5 (0.71) SLC7A5PTGS1ALPIPKMXIAP
Phenylalanine Amide SCHEMBL7613303 0.69 SLC7A5 (0.70) SLC7A5PTGS1ALPIPKMXIAP
Phenylalanine Amide SCHEMBL7613300 0.69 SLC7A5 (0.70) SLC7A5PTGS1ALPIPKMXIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10961273-B2 N-carboxyanhydride-based-scale synthesis of elamipretide STEALTH BIOTHERAPEUTICS CORP. (MC) 2021-03-30 — — US disclosed
US-20190202861-A1 N-CARBOXYANHYDRIDE-BASED-SCALE SYNTHESIS OF ELAMIPRETIDE STEALTH BIOTHERAPEUTICS INC. 2019-07-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10961273-B2 N-carboxyanhydride-based-scale synthesis of elamipretide MTPN, TUFM, PDF SLC7A5 1906/4885PTGS1 2017/4885ALPI 1007/4885
US-20190202861-A1 N-CARBOXYANHYDRIDE-BASED-SCALE SYNTHESIS OF ELAMIPRETIDE MTPN, TUFM, PDF SLC7A5 1906/4885PTGS1 2017/4885ALPI 1007/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback